Apellis Pharmaceuticals, Inc. (APLS)
40.70
+0.07
(+0.17%)
USD |
NASDAQ |
Apr 07, 16:00
40.69
-0.01
(-0.02%)
After-Hours: 20:00
Apellis Pharmaceuticals Cash from Investing (TTM) : -0.313M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Biogen, Inc. | -1.371B |
| Eli Lilly & Co. | -10.97B |
| Agios Pharmaceuticals, Inc. | 377.18M |
| Scholar Rock Holding Corp. | 218.69M |
| BridgeBio Pharma, Inc. | -22.34M |